BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3377152)

  • 1. Adriamycin cardiomyopathy. Fatal outcome of general anaesthesia in a child with adriamycin cardiomyopathy.
    McQuillan PJ; Morgan BA; Ramwell J
    Anaesthesia; 1988 Apr; 43(4):301-4. PubMed ID: 3377152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin (adriamycin) cardiomyopathy.
    Saltiel E; McGuire W
    West J Med; 1983 Sep; 139(3):332-41. PubMed ID: 6356608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatal myocardiopathy due to adriamycin in spite of a reportedly non-dangerous cumulative dose].
    Battin J; Richir C; Bui NB; Hehunstre JP; Abecassis S
    Ann Pediatr (Paris); 1989 Feb; 36(2):136-40. PubMed ID: 2930128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiomyopathy due to adriamycin: the possibility of its prevention. Monitoring by noninvasive technics].
    Bianchi L; Bertocchi C; Felci U; Ferrario G; Giani P; Mariani L; Medolago G; Sarti E
    Minerva Med; 1989 Mar; 80(3):215-26. PubMed ID: 2717043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Congestive cardiomyopathy after doxorubicin (adriamycin)author's transl)].
    Kaduk B; Seiler G
    Dtsch Med Wochenschr; 1977 Dec; 102(49):1813-7. PubMed ID: 271071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin toxicity. Effects in subsequent anesthesia and surgery.
    Caviale P; McClellan EL
    J Kans Med Soc; 1981 Dec; 82(12):553, 574. PubMed ID: 7310218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiotoxic side effects of adriamycin].
    Brockmann B; Matthias M
    Z Arztl Fortbild (Jena); 1983; 77(5):209-11. PubMed ID: 6858220
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
    Jaenke RS
    Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
    Paulides M; Kremers A; Stöhr W; Bielack S; Jürgens H; Treuner J; Beck JD; Langer T;
    Pediatr Blood Cancer; 2006 Apr; 46(4):489-95. PubMed ID: 16333817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiotoxic effects after acute administration of adriamycin].
    Vajola SF; Boccardi L; Cacciatore G; Cipri A; De Angelis G; Minardi G; Pozzar F; Schiavo B
    Boll Soc Ital Cardiol; 1981; 26(11):1413-6. PubMed ID: 7349183
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection from adriamycin-induced cardiomyopathy in rats.
    Shug AL
    Z Kardiol; 1987; 76 Suppl 5():46-52. PubMed ID: 3433883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy].
    Lenzhofer R; Schneeweiss B; Rameis H; Eichler H; Graninger W; Dittrich C; Dudczak R; Ganzinger U; Gasic S; Moser K
    Wien Klin Wochenschr; 1983 Jan; 95(2):52-5. PubMed ID: 6858169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic cardiomyopathies.
    Balazs T; Herman EH
    Ann Clin Lab Sci; 1976; 6(6):467-76. PubMed ID: 793502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin-induced cardiomyopathy.
    Compr Ther; 1979 Apr; 5(4):7. PubMed ID: 445992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic toxicities of adriamycin (ADR) and their possible prevention by coenzyme Q10 and verapamil in rabbits--especially ADR induced cardiomyopathy (author's transl)].
    Dohmae N; Sawada H; Tashima M; Uchino H; Matsuyama E; Konishi T
    Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):1009-28. PubMed ID: 541529
    [No Abstract]   [Full Text] [Related]  

  • 17. Adriamycin-induced myocardial toxicity: new solutions for an old problem?
    Outomuro D; Grana DR; Azzato F; Milei J
    Int J Cardiol; 2007 Apr; 117(1):6-15. PubMed ID: 16863672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocardial fibroelastosis associated with fatal adriamycin (doxorubicin) cardiomyopathy during treatment of Ewing's sarcoma.
    Conroy B; Guthrie W
    Scott Med J; 1983 Jul; 28(3):295-9. PubMed ID: 6612319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.
    Milei J; Bolomo NJ; Marantz A
    Medicina (B Aires); 1982; 42(4):409-14. PubMed ID: 15171023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study on elucidating pathogenesis of adriamycin induced cardiomyopathy (author's transl)].
    Bühner R; Biedert S; Miura D
    Arzneimittelforschung; 1980; 30(7):1065-70. PubMed ID: 7191288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.